Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel PK in Caucasian and African-American Cancer Patients
NCT00003565Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Sep 1998
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of docetaxel in solid tumor, sponsored by Cancer and Leukemia Group B. Started Sep 1998; status: completed.
02
Drugs
docetaxel
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00003565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003565.